| Hang Seng Index | 16.750 HKD | +0.130 | +0.782% | 179.88M | 3.02B | 16.768 (-0.108%) HKD as at 2024/03/28 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 3.050 HKD | +0.148 | +5.100% | 420.51M | 1.28B | 3.060 (-0.317%) HKD as at 2024/03/28 | | |
| Hang Seng China Enterprises | 58.660 HKD | +0.780 | +1.348% | 20.02M | 1.17B | 58.801 (-0.239%) HKD as at 2024/03/28 | | |
| Hang Seng TECH Index | 3.402 HKD | +0.074 | +2.224% | 339.95M | 1.16B | 3.406 (-0.115%) HKD as at 2024/03/28 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 7.035 HKD | -0.370 | -4.997% | 142.38M | 998.00M | 7.024 (+0.157%) HKD as at 2024/03/28 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 2.780 HKD | +0.056 | +2.056% | 191.83M | 532.94M | 2.774 (+0.216%) HKD as at 2024/03/28 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 6.400 HKD | -0.130 | -1.991% | 47.81M | 305.53M | 6.418 (-0.282%) HKD as at 2024/03/28 | | |
| Hang Seng TECH Index | 7.310 HKD | +0.210 | +2.958% | 16.11M | 117.30M | 7.114 (+2.758%) HKD as at 2024/03/27 | | |
| CSI 300 | 39.100 HKD | +0.180 | +0.462% | 1.85M | 72.34M | 38.997 (+0.265%) HKD as at 2024/03/28 | | |
| FTSE China A50 | 11.740 HKD | +0.030 | +0.256% | 5.00M | 58.59M | 11.701 (+0.338%) HKD as at 2024/03/28 | | |
| CME Bitcoin Futures | 27.880 HKD | +0.400 | +1.456% | 2.05M | 56.65M | 27.036 (+3.120%) HKD as at 2024/03/27 | | |
| FTSE China A50 | 12.370 HKD | +0.030 | +0.243% | 3.62M | 44.64M | 12.368 (+0.015%) HKD as at 2024/03/27 | | |
| Hang Seng TECH Index | 3.430 HKD | +0.058 | +1.720% | 12.27M | 42.28M | 3.445 (-0.444%) HKD as at 2024/03/28 | | |
| CME Ether Futures | 19.890 HKD | +0.150 | +0.760% | 1.18M | 23.21M | 19.328 (+2.907%) HKD as at 2024/03/27 | | |
| London Gold Fixing Price | 1,589.000 HKD | +9.500 | +0.601% | 14.09K | 22.40M | 1,573.023 (+1.016%) HKD as at 2024/03/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 8.850 HKD | +0.095 | +1.085% | 2.14M | 19.01M | 8.848 (+0.020%) HKD as at 2024/03/27 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 6.655 HKD | -0.015 | -0.225% | 1.36M | 9.04M | 6.656 (-0.015%) HKD as at 2024/03/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 1.670 HKD | +0.056 | +3.470% | 5.01M | 8.30M | 1.655 (+0.882%) HKD as at 2024/03/28 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 6.070 HKD | -0.070 | -1.140% | 1.34M | 8.14M | 6.084 (-0.232%) HKD as at 2024/03/28 | | |
| FTSE China A50 | 10.860 CNY | 0.000 | 0.000% | 561.49K | 6.11M | 10.847 (+0.118%) CNY as at 2024/03/28 | | |
| Hang Seng High Dividend Yield | 19.480 HKD | +0.100 | +0.516% | 303.10K | 5.88M | 19.331 (+0.772%) HKD as at 2024/03/27 | | |
| Mirae Asset Global Innovative Bluechip Top 10 Index | 63.720 HKD | -0.160 | -0.250% | 80.72K | 5.12M | 63.484 (+0.372%) HKD as at 2024/03/27 | | |
| Nikkei Stock Average Index (net total return version) | 85.240 HKD | -0.120 | -0.141% | 54.74K | 4.68M | 85.058 (+0.215%) HKD as at 2024/03/28 | | |
| Hang Seng TECH Index | 4.378 HKD | +0.104 | +2.433% | 1.03M | 4.52M | 4.388 (-0.232%) HKD as at 2024/03/28 | | |
| Solactive China Little Giant Index | 46.000 HKD | +0.900 | +1.996% | 91.00K | 4.17M | 45.249 (+1.660%) HKD as at 2024/03/27 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.995 HKD | -0.004 | -0.400% | 3.94M | 3.93M | 0.997 (-0.171%) HKD as at 2024/03/27 | | |
| FTSE Saudi Arabia Index (net total return version) | 80.580 CNY | +0.680 | +0.851% | 47.67K | 3.84M | 80.396 (+0.228%) CNY as at 2024/03/27 | | |
| MSCI Asia APEX 50 | 6.560 USD | +0.040 | +0.613% | 569.30K | 3.73M | 6.503 (+0.883%) USD as at 2024/03/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.404 HKD | +0.052 | +1.551% | 1.01M | 3.45M | 3.403 (+0.035%) HKD as at 2024/03/28 | | |
| BSE SENSEX | 39.200 HKD | +0.580 | +1.502% | 84.80K | 3.31M | 38.619 (+1.504%) HKD as at 2024/03/27 | | |